STEPHEN L. MAYO, PH.D.

Corporate Board Profile

Tech Score: 100/100

← Back to All Directors

Software Technology Evidence

2 mention(s) identify STEPHEN L. MAYO, PH.D. as having software/technology expertise.

Company Filing Date Evidence Reason
Merck & Co., Inc. 2021-04-05 Dr. Mayo has extensive scientific experience relevant to the biopharmaceutical industry, including being the Bren Professor of Biology and Chemistry. Dr. Mayo has extensive scientific experience relevant to the biopharmaceutical industry and has overseen technology licensing, indicating technical expertise.
Merck & Co., Inc. 2022-04-04 Dr. Mayo has extensive scientific experience relevant to the biopharmaceutical industry. Dr. Mayo has extensive scientific experience and has overseen technology licensing, indicating familiarity with technical aspects of scientific research.

Merck & Co., Inc.

Filing Date Source Excerpt
2021-04-05 Dr. Mayo has extensive scientific experience relevant to the biopharmaceutical industry, including being the Bren Professor of Biology and Chemistry.
2022-04-04 Dr. Mayo has extensive scientific experience relevant to the biopharmaceutical industry.

Data sourced from SEC filings. Last updated: 2025-07-01